Quipt Home Medical's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Quipt Home Medical (QIPT) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Quipt Home Medical vs Its Competitors
- TTM: Trailing 12-month revenue of 265M vs 28,581M combined for tracked competitors (0.9% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+22.3% annualized vs trailing 12 months), vs holding steady (+0.7%) for its tracked peer group.
- Growth: Quipt Home Medical generated 32.0% revenue growth year over year in Q1 2025, vs 7.4% for its tracked competitors combined.
- Profitability: Its -0.9% net margin compares with 5.2% for the peer group.
- Peer revenue share: Quipt Home Medical accounted for 1.1% of combined revenue among its tracked peer group, up from 0.9% a year earlier.
- Peer differentiation: Revenue per employee of $0.17M compares with $0.13M for the peer group (1.3x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
QIPT Sales vs. its Competitors, Q1 2025
Quipt Home Medical reported revenue growth of 31.96 % year on year in Q1 2025, above its competitors' combined revenue growth of 7.44 %.
With a net margin of -0.88 %, Quipt Home Medical reported lower profitability than its competitors (5.20 %).
Quipt Home Medical generated 1.11 % of the combined sales of its peer group, up from 0.91 % a year earlier.
Quipt Home Medical vs. its Competitors, Q1 2025
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Quipt Home Medical and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Quipt Home Medical Corp | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (1) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (2) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Quipt Home Medical's competitor groups requires a Commercial License.
For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs 32.0% for Quipt Home Medical. Quipt Home Medical's share of combined industry revenue moved from 0.06% to 0.07%, a gain of 0.01 percentage points.
Quipt Home Medical's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Quipt Home Medical Corp | No | No | No | Yes |
| Competitors combined (12) | ||||
| High-Confidence Competitors (2) | ||||
| Similar Growth & Profitability (8) | 25.00 % (2 of 8) | 0.00 % (0 of 8) | 0.00 % (0 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
QIPT Stock Performance relative to its Competitors
QIPT Stock Performance relative to High-Confidence Competitors
QIPT Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Aveanna Healthcare Holdings Inc | 282.9% | Outperformed |
| 2 | Sonida Senior Living Inc | 282.9% | Outperformed |
| 3 | Viemed Healthcare Inc | 282.9% | Outperformed |
| 4 | Brookdale Senior Living Inc | 282.9% | Outperformed |
| 5 | Enhabit Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Quipt Home Medical's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Quipt Home Medical's Comment on Competition and Industry Peers
Publicly Traded Peers of Quipt Home Medical Corp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Quipt Home Medical Corp | 159.17 | 264.97 |
| Encompass Health Corporation | 12,402.00 | 6,206.10 |
| Chemed Corporation | 6,788.25 | 2,595.00 |
| Option Care Health Inc | 3,622.99 | 5,666.58 |
| Amedisys Inc | 3,361.86 | 2,402.37 |
| Aveanna Healthcare Holdings Inc | 2,853.52 | 2,602.82 |
| SUBTOTAL | 39,034.04 | 31,247.93 |
Sign in to see all competitors of Quipt Home Medical Corp .
Sources: Quipt Home Medical Corp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Quipt Home Medical Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Quipt Home Medical's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Apria | Named by the company | 85% |
| Accendra Health inc | Named by the company | 85% |
| Lincare | Named by the company | 85% |
| Rotech | Named by the company | 85% |
| Adapt Healthcare | Named by the company | 85% |
| Adapthealth Corp | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Quipt Home Medical's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Quipt Home Medical's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Encompass Health Corporation | Inpatient Rehabilitation 100.00 % |
| Chemed Corporation | Segment Vitas 65.85 % |
| Option Care Health Inc | Reportable 100.00 % |
| Aveanna Healthcare Holdings Inc | Private Duty Services 82.67 % |
| Brookdale Senior Living Inc | Assisted Living and Memory Care 71.89 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Quipt Home Medical Corp .
Quipt Home Medical's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Quipt Home Medical Corp | 159 | 165,609 | -6,381 |
| Encompass Health Corporation | 12,402 | 147,764 | 19,840 |
| Chemed Corporation | 6,788 | 164,126 | 17,393 |
| Option Care Health Inc | 3,623 | 685,528 | 24,944 |
| Amedisys Inc | 3,362 | 126,440 | 4,309 |
| Aveanna Healthcare Holdings Inc | 2,854 | 743,663 | 78,503 |
| PEERS TOTAL | 38,875 | 131,029 | 6,039 |
Sign in to see all peers for Quipt Home Medical Corp .
Quipt Home Medical's Position in Industry Market Structure
Market-capitalization share and concentration across all 48 companies in Quipt Home Medical's industry classification, broader than the peer set above. Market cap in millions of $.Quipt Home Medical ranks #0 of 48 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,749, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Hca Healthcare Inc | 100,440 | 38.81 % |
| 2 | Tenet Healthcare Corp | 22,258 | 8.60 % |
| 3 | Fresenius Medical Care Ag | 13,424 | 5.19 % |
| 4 | Brightspring Health Services Inc | 12,539 | 4.84 % |
| 5 | Encompass Health Corporation | 1,234 | 5.2% |
| 6 | Davita Inc | 1,234 | 5.2% |
| 7 | Universal Health Services Inc | 1,234 | 5.2% |
| 8 | Ensign Group Inc | 1,234 | 5.2% |
| 9 | Pacs Group Inc | 1,234 | 5.2% |
| 10 | Chemed Corporation | 1,234 | 5.2% |
| 0 | Quipt Home Medical Corp | 159 | 0.00 % |
Market cap and industry share for the rest of Quipt Home Medical's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-03-13.
Quipt Home Medical's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Healthcare Facilities industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (77 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 72.38 % | 52.28 % (avg) | +20.1 pp |
| Operating Margin | -1.23 % | industry median | -9.6 pp |
| EBITDA Margin | 11.93 % | 3.22 % (avg) | +8.7 pp |
| Capital Intensity (Capex / Revenue) | 4.06 % | 4.01 % (avg) | +0.1 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Quipt Home Medical's Valuation vs Competitive Position
Valuation multiples vs the Healthcare Facilities industry average (77 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 23.5x | - |
| EV / EBITDA | 6.3x | 15.7x | -9.4x |
| P/B | 1.2x | 3.3x | -2.1x |
| Return on Equity | -9.47 % | industry aggregate | -38.55 % |
| Return on Invested Capital | -1.01 % | 4.91 % (avg) | -5.92 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Quipt Home Medical's Strategic Group Map
Every company in Quipt Home Medical's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Quipt Home Medical is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Quipt Home Medical's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,749 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Moderate, in line with the industry | Capital intensity (capex / revenue) of 4.06 % vs industry average 4.01 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Quipt Home Medical's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Quipt Home Medical's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Quipt Home Medical's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Quipt Home Medical falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Quipt Home Medical's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+22.3% annualized vs trailing 12 months).
- Outperforming the U.S.A. 500 over the trailing 12 months.
Weaknesses
- Operating margin 9.6 points below the industry median.
- Return on equity 38.6 points below the industry aggregate.
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- Industry dominated by Hca Healthcare Inc , holding 38.81 % of industry market cap.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Quipt Home Medical's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Quipt Home Medical Corp | 0.19 | 1.11 | 0.74 |
| Encompass Health Corporation | 0.10 | 1.15 | 0.98 |
| Chemed Corporation | 0.21 | 1.04 | 0.06 |
| Option Care Health Inc | 0.29 | 1.56 | 0.85 |
| Amedisys Inc | 0.59 | 1.27 | 0.30 |
| Aveanna Healthcare Holdings Inc | 0.38 | 1.29 | 7.13 |
Sign in to see all peers for Quipt Home Medical Corp .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Quipt Home Medical's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Quipt Home Medical Corp | Q4 2025 | +32.0 % | - |
| Encompass Health Corporation | Q2 2026 | +9.6 % | +12.2 % |
| Chemed Corporation | Q2 2026 | +8.8 % | +29.0 % |
| Option Care Health Inc | Q1 2026 | +1.3 % | -3.0 % |
| Amedisys Inc | Q2 2025 | +5.2 % | -10.8 % |
| Aveanna Healthcare Holdings Inc | Q2 2026 | +13.7 % | +49.1 % |
| PEERS TOTAL | +4.9 % | +1.0 % |
Sign in to see all peers for Quipt Home Medical Corp .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Quipt Home Medical's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Quipt Home Medical Corp | Q4 2025 | +28.2 % | -43.7 % |
| Encompass Health Corporation | Q2 2026 | - | +40.4 % |
| Chemed Corporation | Q2 2026 | +4.1 % | -1.8 % |
| Option Care Health Inc | Q1 2026 | +1.7 % | -3.5 % |
| Amedisys Inc | Q2 2025 | +6.6 % | -41.1 % |
| Aveanna Healthcare Holdings Inc | Q2 2026 | +19.3 % | - |
Sign in to see all peers for Quipt Home Medical Corp .
Quipt Home Medical's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Quipt Home Medical Corp | - | - | - |
| Encompass Health Corporation | 11.60% | 11.56% | 25.52% |
| Chemed Corporation | 17.52% | 20.13% | 29.45% |
| Option Care Health Inc | 6.02% | 7.82% | 15.28% |
| Amedisys Inc | 3.77% | 4.60% | 6.68% |
| Aveanna Healthcare Holdings Inc | 13.82% | 16.32% | 150.35% |
Sign in to see all peers for Quipt Home Medical Corp .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Quipt Home Medical's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Quipt Home Medical Corp | - | 0.60 |
| Encompass Health Corporation | 20.20 | 2.00 |
| Chemed Corporation | 364.75 | 2.62 |
| Option Care Health Inc | 17.89 | 0.64 |
| Amedisys Inc | 39.30 | 1.40 |
| Aveanna Healthcare Holdings Inc | 57.68 | 1.10 |
| PEERS AVERAGE | 27.53 | 1.25 |
Sign in to see all peers for Quipt Home Medical Corp .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.